Cargando…

Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis

The use of local antibiotics from a biodegradable implant for chronic osteomyelitis is an attractive alternative. The implant delivers high antibiotic concentration at tissue levels, obliterates dead space, aids bone repair and does not need to be removed. The purpose of this paper is to develop and...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, A., Pundir, R., Pandian, C. S., Saraf, S., Gupta, H.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865808/
https://www.ncbi.nlm.nih.gov/pubmed/20502542
http://dx.doi.org/10.4103/0250-474X.57285
_version_ 1782180876259426304
author Anand, A.
Pundir, R.
Pandian, C. S.
Saraf, S.
Gupta, H.
author_facet Anand, A.
Pundir, R.
Pandian, C. S.
Saraf, S.
Gupta, H.
author_sort Anand, A.
collection PubMed
description The use of local antibiotics from a biodegradable implant for chronic osteomyelitis is an attractive alternative. The implant delivers high antibiotic concentration at tissue levels, obliterates dead space, aids bone repair and does not need to be removed. The purpose of this paper is to develop and evaluate a calcium sulphate and polycaprolactone based composite biodegradable implantable delivery system of cefoperazone sodium. Implants were prepared by modified fabrication technique to avoid solvent use. Interaction studies were carried out to check any incompatibility between ingredients. Prepared implants were evaluated for various in vitro parameters like dimensions, hardness, tensile strength, drug release profile and sterility. Morphological changes in pellet before and after drug release were evaluated by scanning electron microscopy. The pellet were also tested for microbiological efficacy and compared with plain drug solution in different concentrations. Developed pellets are regular in shape and size with good tensile strength. The release profile displayed drug levels above MIC continuously up to 2 months. Wide zone of inhibition by pellet against Staph. aureus as compared to drug solution proves its efficacy in treatment of osteomyelitis.
format Text
id pubmed-2865808
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28658082010-05-25 Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis Anand, A. Pundir, R. Pandian, C. S. Saraf, S. Gupta, H. Indian J Pharm Sci Research Paper The use of local antibiotics from a biodegradable implant for chronic osteomyelitis is an attractive alternative. The implant delivers high antibiotic concentration at tissue levels, obliterates dead space, aids bone repair and does not need to be removed. The purpose of this paper is to develop and evaluate a calcium sulphate and polycaprolactone based composite biodegradable implantable delivery system of cefoperazone sodium. Implants were prepared by modified fabrication technique to avoid solvent use. Interaction studies were carried out to check any incompatibility between ingredients. Prepared implants were evaluated for various in vitro parameters like dimensions, hardness, tensile strength, drug release profile and sterility. Morphological changes in pellet before and after drug release were evaluated by scanning electron microscopy. The pellet were also tested for microbiological efficacy and compared with plain drug solution in different concentrations. Developed pellets are regular in shape and size with good tensile strength. The release profile displayed drug levels above MIC continuously up to 2 months. Wide zone of inhibition by pellet against Staph. aureus as compared to drug solution proves its efficacy in treatment of osteomyelitis. Medknow Publications 2009 /pmc/articles/PMC2865808/ /pubmed/20502542 http://dx.doi.org/10.4103/0250-474X.57285 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Anand, A.
Pundir, R.
Pandian, C. S.
Saraf, S.
Gupta, H.
Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis
title Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis
title_full Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis
title_fullStr Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis
title_full_unstemmed Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis
title_short Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis
title_sort cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865808/
https://www.ncbi.nlm.nih.gov/pubmed/20502542
http://dx.doi.org/10.4103/0250-474X.57285
work_keys_str_mv AT ananda cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis
AT pundirr cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis
AT pandiancs cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis
AT sarafs cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis
AT guptah cefoperazonesodiumimpregnatedpolycaprolactonecompositeimplantforosteomyelitis